IP Library Granted Patent US 11,980,215
Granted Patent B2
US 11,980,215 · App. 17/749,828 · Granted May 14, 2024

Synthetic milk compositions for infants less than three months old and for infants and children more than three months for ensuring optimal growth and preventing obesity

Inventors: Carlos Antonio DeCastro (Geneva, CH); Cristina Cruz-Hernandez (Epalinges, CH); Frederic Destaillats (Servion, CH); Francesca Giuffrida (Mezieres, CH); Sagar Thakkar (St-Legier, CH); Rajat Mukherjee (Montreux, CH)
Assignee: Societe des Produits Nestle S.A.
A23L33/40A23L33/115A23L33/12A23L33/17A23L33/30A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,980,215
App. No.
17/749,828
Granted
May 14, 2024
Kind
B2
Abstract

Synthetic nutritional formulations, particularly milk based compositions, for infants and children are especially adapted to the age of the child. They are adapted to fulfill the nutritional needs of the child, ensuring balanced growth and development and thereby reducing the risk of obesity.

Claims (28)

1. A method for ensuring balanced growth in an infant or young child older than three months old and preventing obesity in the infant or young child during childhood and later in life, the method comprising administering a synthetic composition to the infant or young child, the synthetic composition comprising:

0.7-0.9 g/100 ml protein,

4.2-5.2 g/100 ml lipid, and

at least one phospholipid selected from the group consisting of:

3.8-5.2 mg/100 ml of phosphatidylcholine,

7.3-8.9 mg/100 ml of phosphatidylethanolamine, and

1.5-1.9 mg/100 ml of phosphatidylinositol.

2. The method of claim 1 , wherein the balanced growth is defined according to indicators defined by World Health Organization (WHO).

3. The method of claim 1 , wherein the infant or young child was preterm and/or caesarean born.

4. The method of claim 1 , wherein the infant or young child was born from a mother having obesity or overweight.

5. The method of claim 1 , wherein the ensuring balanced growth comprises promoting balanced growth.

6. The method of claim 1 , wherein the preventing obesity comprises reducing a risk of obesity.

7. The method of claim 1 , wherein the at least one phospholipid comprises 4.8-5.2 mg/100 ml of phosphatidylcholine.

8. The method of claim 1 , wherein the at least one phospholipid comprises 7.3-8.9 mg/100 ml of phosphatidylethanolamine.

9. The method of claim 1 , wherein the at least one phospholipid comprises 1.5-1.9 mg/100 ml of phosphatidylinositol.

10. The method of claim 1 , wherein the at least one phospholipid comprises 4.8-5.2 mg/100 ml of phosphatidylcholine, 7.3-8.9 mg/100 ml of phosphatidylethanolamine, and 1.5-1.9 mg/100 ml of phosphatidylinositol.

11. The method of claim 1 , wherein the at least one phospholipid is selected from the group consisting of:

3.8-5.2 mg/100 ml of phosphatidylcholine,

7.5-8.2 mg/100 ml of phosphatidylethanolamine, and

1.6-1.8 mg/100 ml of phosphatidylinositol.

12. The method of claim 1 , wherein the synthetic composition is an infant formula.

13. The method of claim 1 , wherein the protein comprises whey protein and casein.

14. The method of claim 1 , wherein the synthetic composition further comprises a probiotic.

15. The method of claim 14 , wherein the probiotic comprises B. longum.

16. The method of claim 14 , wherein the probiotic comprises Lactobacillus Rhamnosus.

17. The method of claim 1 , wherein the synthetic composition further comprises at least one fatty acid.

18. The method of claim 17 , wherein the at least one fatty acid is selected from the group consisting of an alpha-linolenic acid, an omega-3 fatty acid, a linoleic acid, and an omega-6 fatty acid.

19. The method of claim 18 , wherein the at least one fatty acid comprises alpha-linolenic acid and linoleic acid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2024
From: DE CASTRO, CARLOS ANTONIO; CRUZ-HERNANDEZ, CRISTINA; DESTAILLATS, FREDERIC; GIUFFRIDA, FRANCESCA; THAKKAR, SAGAR
To: NESTEC S.A.
Reel/Frame 066177/0532 →
MERGER Recorded Jan 19, 2024
From: NESTEC S.A.
To: SOCIETE DES PRODUITS NESTLE S.A.
Reel/Frame 066177/0578 →
Priority Claims (1)
EP 13196800 · Dec 12, 2013 · regional
Continuity (2)
Division 15103961
Related Publication 20220304359A1 · Sep 29, 2022